HRMY Harmony Biosciences Holdings, Inc.
$32.59 -1.18%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-1.18%
YTD
-12.90%
P/E
10.72
P/B
2.48
ROE
18.6%
Div yield
—
Beta
0.62
Market cap
$1.9B
RSI (14)
32
Next earnings
—
Same sector · Health Care
Compare HRMY with NVO and JNJ →Follow HRMY in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$32.68
Close
$32.59
Day high
$33.42
Day low
$32.51
Volume
583K
Latest headlines
Harmony Biosciences to Participate in Upcoming Investor Conferences
Yahoo Finance · Nov 19
Harmony Biosciences (HRMY) Stock May Be Undervalued On Earnings Power
Yahoo Finance · Nov 7
HRMY Q3 Earnings Miss Estimates on Higher Costs Despite Wakix Growth
Yahoo Finance · Nov 5
Harmony Biosciences Holdings, Inc. Q3 2026 Earnings Call Summary
Yahoo Finance · Nov 4
Harmony Biosciences (HRMY) Q3 2026 Earnings Call Transcript
Yahoo Finance · Nov 4
Harmony Biosciences Q3 Earnings Call Highlights
Yahoo Finance · Nov 4
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Nov 4, 2026 View → 8-K Nov 4, 2026 View → 8-K Oct 13, 2026 View → 10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell HRMY. Try it in the Lab to size a position and see the risk.